KK
IMNM icon

KLP Kapitalforvaltning’s Immunome IMNM Stock Holding History

KLP Kapitalforvaltning’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$432K Hold
20,400
– – ﹤0.01% 1564
2026
Q1 		$446K Buy
20,400
+5,400
+36% +$120K ﹤0.01% 1475
2025
Q4 		$322K Buy
15,000
+1,800
+14% +$31.6K ﹤0.01% 1630
2025
Q3 		$155K Hold
13,200
– – ﹤0.01% 1913
2025
Q2 		$123K Sell
13,200
-3,900
-23% -$32K ﹤0.01% 1971
2025
Q1 		$115K Buy
17,100
+10,000
+141% +$95.9K ﹤0.01% 1970
2024
Q4 		$75.4K Buy
+7,100
New +$85.8K ﹤0.01% 2168

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

KLP Kapitalforvaltning's IMNM Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Immunome (IMNM) position steady in Q2 2026 at 20,400 shares worth $432K. The position accounts for ﹤0.01% of the portfolio, ranked #1564.

KLP Kapitalforvaltning first reported a position in IMNM in Q4 2024 and has held it in 7 quarters since. The position peaked at $446K in Q1 2026. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • KLP Kapitalforvaltning held 20,400 shares of Immunome worth $432K as of Q2 2026.
  • KLP Kapitalforvaltning left its Immunome share count unchanged in Q2 2026.
  • Immunome made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1564 holding.
  • KLP Kapitalforvaltning first reported a position in Immunome in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Immunome position peaked at $446K in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.